First patient dosed with ZI-MA4-1 in the ZIMA-101 Phase 1 trial at The Christie NHS Foundation TrustZI-MA4-1 is the world’s first MAGE-A4-targeting TCR-NK therapy in clinical developmentZIMA-101 ...
The American Red Cross on Monday declared an emergency blood shortage as the blood supply fell nearly 25% in June. The Red ...
Our success has really been driven by implementing standardized screening processes across multiple clinical settings," said Dr. Steven Dobscha.
Pulmonary arterial hypertension (PAH) is a rare, progressive disease of the precapillary pulmonary arteries, characterized by ...
Rather than focusing only on symptom reduction, values-based treatment helps people build a life worth moving toward.
New results from an Alliance Foundation Trials (AFT) study reveal that a simple weekly electronic symptom check-in with care team, significantly improves the quality of life for individuals undergoing ...
The Oakland score outperformed several risk assessments and should be used alongside clinical judgment when determining which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results